|
Many of the standard cancer treatments used today are the result of clinical trials. Clinical trials are an integral part of cancer research because they focus on finding new, and sometimes improved, ways to prevent, diagnose, treat and manage cancer. You deserve personalized treatment plans that maximize results and minimize side effects. Participating in a clinical trial of a new treatment or procedure may be an option for you.
Norton Cancer Institute offers more than 50 innovative National Cancer Institute and industry-sponsored clinical trials in which you may qualify to participate. Our participation in these research studies allows us to offer many patients the latest, most advanced therapies for cancer – and often those that are unavailable elsewhere.
The Norton Cancer Institute Research Program has made remarkable strides and discoveries through participation in clinical trials. These breakthroughs hold promise for patients by improving the ability of our specialists to target and detect cancers early, while they are the most treatable.
Research Leadership
 |
|
John T. Hamm, M.D.
Medical Director, Research Program
Dr. Hamm is one of the four founders of Norton Cancer Institute. A Louisville native, he received his medical degree at Vanderbilt University and completed his formal training in Louisville. Dr. Hamm is board certified in internal medicine with a subspecialty in medical oncology. He is chairman of the Norton Hospital Cancer Committee.
|
For more information on available studies, call (502) 629-3465.
Research Program
Norton Cancer Institute
315 E. Broadway
Louisville , KY 40202
(502) 629-3465 |
